knowledge -WSS

knowledge

author：fashion 2025-10-01 05:38:44 - browse：9

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large trial showing the company’s obesity drug Wegovy cut the risk of heart complications by 20%.

But once again, much of the attention was focused on the company’s struggles to meet what Novo CEO Lars Fruergaard Jørgensen referred to as the “overwhelming demand for Wegovy.”

Jørgensen reiterated that the company was racing to expand supply and had brought on more contract manufacturing support, but Novo said Thursday that the company would continue to restrict the availability of lower-strength starter doses in the United States to ensure that patients on the drug would not have their medication interrupted.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： 6 phony surgeries that take placebo to the extreme

focus

WSS

Iowa House, Senate pass 6

What to know about OceanGate, the company behind the missing Titanic submersible

Oak trusses raised to roof of fire

California’s proposed $25 per hour health care minimum wage

Medicare inequities exacerbate Puerto Rico’s health disparities

Alabama hospital puts IVF treatments on hold

leisure time

knowledge

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Peter Hotez and the public health issue of online harassment

Why palliative psychiatry is worth discussing

After affirmative action ruling, medical educators look to 'holistic review'

Alabama IVF ruling threatens families facing fatal genetic disease

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How the political right came to back psychedelics to treat trauma

Tori Bowie and the unacceptable rates of Black maternal death

Charles Manson follower Leslie Van Houten released from prison after 53 years

explore

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Beach reads and more: STAT's 2023 summer book list

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

New research casts further doubt on a common procedure used with IVF

Beach reads and more: STAT's 2023 summer book list

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

focus

focus

focus

knowledge